Use of prophylactic antifungals in the immunocompromised host.
about
Periodontal conditions, oral Candida albicans and salivary proteins in type 2 diabetic subjects with emphasis on genderEfflux-mediated antifungal drug resistance.Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.Treatment strategies for oropharyngeal candidiasis.
P2860
Use of prophylactic antifungals in the immunocompromised host.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Use of prophylactic antifungals in the immunocompromised host.
@ast
Use of prophylactic antifungals in the immunocompromised host.
@en
type
label
Use of prophylactic antifungals in the immunocompromised host.
@ast
Use of prophylactic antifungals in the immunocompromised host.
@en
prefLabel
Use of prophylactic antifungals in the immunocompromised host.
@ast
Use of prophylactic antifungals in the immunocompromised host.
@en
P1476
Use of prophylactic antifungals in the immunocompromised host
@en
P2093
Arjan Vissink
Jonathan A Ship
P304
P356
10.1016/J.TRIPLEO.2006.11.003
P478
P577
2007-03-01T00:00:00Z